Allogeneic double‐negative T cells as a novel adoptive cellular immunotherapy for relapsed AML post allo‐HSCT : a first‐in‐human phase I study

American Journal of Hematology(2022)

引用 2|浏览16
暂无评分
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要